[Form 3] Connect Biopharma Holdings Ltd Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Connect Biopharma Holdings Ltd director Jean I Liu filed an initial ownership report detailing several stock options over Ordinary Shares. The options have exercise prices that include $22.29, $4.12, $1.27, $1.18, $0.96 and $2.50, with expiration dates ranging from 2031 through 2036.

The filing notes that one stock option is already fully vested and exercisable, while another will fully vest and become exercisable on March 2, 2027. The report lists holdings only and does not show any purchases or sales.

Insider Trade Summary

6 transactions reported

Mixed 6 txns

Insider LIU JEAN I

Role Director

Type	Security	Shares	Price	Value
holding	Stock Option (Right to Buy)	--	--	--
holding	Stock Option (Right to Buy)	--	--	--
holding	Stock Option (Right to Buy)	--	--	--
holding	Stock Option (Right to Buy)	--	--	--
holding	Stock Option (Right to Buy)	--	--	--
holding	Stock Option (Right to Buy)	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 34,000 shares (Direct)

Footnotes (1)

1. The stock option is fully vested and exercisable. The stock option fully vests and becomes exercisable on March 2, 2027.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

LIU JEAN I

(Last) (First) (Middle)

3580 CARMEL MOUNTAIN ROAD, SUITE 200

(Street)

SAN DIEGO CA 92130

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/16/2026

3. Issuer Name and Ticker or Trading Symbol
Connect Biopharma Holdings Ltd [ CNTB ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	08/20/2031	Ordinary Shares	34,000	$22.29	D
Stock Option (Right to Buy)	(1)	03/01/2032	Ordinary Shares	21,269	$4.12	D
Stock Option (Right to Buy)	(1)	03/01/2033	Ordinary Shares	21,269	$1.27	D
Stock Option (Right to Buy)	(1)	03/01/2034	Ordinary Shares	26,450	$1.18	D
Stock Option (Right to Buy)	(1)	06/24/2035	Ordinary Shares	60,000	$0.96	D
Stock Option (Right to Buy)	(2)	03/02/2036	Ordinary Shares	60,000	$2.5	D

Explanation of Responses:

1. The stock option is fully vested and exercisable.

2. The stock option fully vests and becomes exercisable on March 2, 2027.

Remarks:

	/s/ Lisa Peraza attorney-in-fact for Jean I Liu	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.